101 - DAK / KKH - Mebeverine - A03AA04 (FTA / UTA)
This tender has been awarded
Awarded to PUREN Pharma GmbH & Co. KG; Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg; Recordati Rare Diseases Germany GmbH; Glenmark Arzneimittel GmbH; Aristo Pharma GmbH — €218,240,377
About This Opportunity
This is a supplies contract in the health and medical services sector. Located in Germany, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 116,021.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from GermanData provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on August 7, 2026. Last refreshed 91 days ago. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About DAK-Gesundheit
DAK-Gesundheit has issued 328 procurement notices on BidsFactory, including 145 currently open and 110 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Germany. Notices are distributed via TED - Tenders Electronic Daily (EU), service.bund.de (Germany), and DÖE Bekanntmachungsservice (Germany). Most recent publication: November 17, 2026.
DAK-Gesundheit: buyer profile, tenders and awardsFrequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
PUREN Pharma GmbH & Co. KG; Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg; Recordati Rare Diseases Germany GmbH; Glenmark Arzneimittel GmbH; Aristo Pharma GmbH was awarded the contract for €218,240,377. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to PUREN Pharma GmbH & Co. KG; Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg; Recordati Rare Diseases Germany GmbH; Glenmark Arzneimittel GmbH; Aristo Pharma GmbH. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by DAK-Gesundheit in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.